STOCK TITAN
  1. Home
  2. IMPL

IMPL Stock Price, News & Analysis

IMPL NASDAQ

Company Description

IMPL (NASDAQ: IMPL) is a publicly traded research and development in biotechnology company in the Professional, Scientific, and Technical Services sector.

IMPL stock has declined 99.1% over the past year.

This page provides a comprehensive overview of IMPL stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
-99.13%
Performance 1 year
$0.0
Market Cap
0.0
Shares outstanding

IMPL (IMPL) stock. Over the past 12 months, the stock has lost 99.1%.

Latest News

View All
December 20, 2023
-27.27%

Impel Pharmaceuticals Announces Filing of Voluntary Chapter 11 Cases and Signing of "Stalking Horse" Agreement to Facilitate Sale

October 5, 2023
+2.92%

Impel Pharmaceuticals Announces Exploration of Strategic Alternatives

June 15, 2023
+2.36%

Impel Pharmaceuticals to Present New Real-World Data for Trudhesa® at the 65th Annual Scientific Meeting of the American Headache Society

conferences
May 12, 2023
-33.33%

Impel Pharmaceuticals Announces First Quarter 2023 Financial Results and Provides Business Update

earnings
May 10, 2023
-4.71%

Impel Pharmaceuticals Announces Appointment of Michael W. Kalb as Chief Financial Officer

management
May 5, 2023
+12.55%

Impel Pharmaceuticals to Report First Quarter 2023 Financial Results on Friday, May 12, 2023

conferences earnings

IMPL has 10 recent news articles. Of the recent coverage, 7 articles coincided with positive price movement and 3 with negative movement. Key topics include conferences, earnings, management. View all IMPL news →

SEC Filings

View All

No SEC filings available for IMPL.

Financial Highlights

View Full Financials
—
Revenue (TTM)
—
Net Income (TTM)
—
Diluted EPS (TTM)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

IMPL Company Profile & Sector Positioning

IMPL (IMPL) operates in the Research and Development in Biotechnology industry within the broader Professional, Scientific, and Technical Services sector and is listed on the NASDAQ.